Phase I dose-escalation trial investigating the safety and tolerability of EP0906 plus estramustine in patients with advanced cancer.

被引：0
|
作者：
Wojtowicz, M
Rothermel, JD
Anderson, J
Todd, M
Rubin, EH
Dipaola, RS
机构：
[1] Canc Inst New Jersey, New Brunswick, NJ USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4623
引用
收藏
页码：412S / 412S
页数：1
相关论文
共 50 条
  • [41] Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies
    Doi, Toshihiko
    Boku, Narikazu
    Onozawa, Yusuke
    Takahashi, Keishiro
    Kawaguchi, Osamu
    Ohtsu, Atsushi
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1390 - 1399
  • [42] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial).
    Varga, Andreea
    Baldini, Capucine
    Martin-Romano, Patricia
    Besse, Benjamin
    Planchard, David
    Champiat, Stephane
    Angevin, Eroc
    Hollebecque, Antoine
    Bahleda, Rastislav
    Gazzah, Anas
    Armand, Jean-Pierre
    Paoletti, Xavier
    Massard, Christophe
    Soria, Jean-Charles
    Marabelle, Aurelien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Phase I dose-escalation trial of tremelimumab in combination with bicalutamide in patients with recurrent prostate cancer
    Lang, J. M.
    Staab, M. J.
    Liu, G.
    Wilding, G.
    McNeel, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [44] Safety, tolerability, and pharmacokinetics of idebenone in a dose-escalation trial in patients with Friedreich's ataxia.
    Di Prospero, NA
    Sumner, C
    Atkinson, A
    Fischbeck, K
    Taylor, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P68 - P68
  • [45] Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Varga, Andreea
    Baldini, Capucine
    Martin-Romano, Patricia
    Hollebecque, Antoine
    Gazzah, Anas
    Bahleda, Rastislav
    Menis, Jessica
    Champiat, Stephane
    El-Dakdouki, Yolla
    Paoletti, Xavier
    Ribrag, Vincent
    Michot, Jean-Marie
    Rafie, Saloomeh
    Planchard, David
    Besse, Benjamin
    Massard, Christophe
    Soria, Jean-Charles
    Marabelle, Aurelien
    CANCER RESEARCH, 2018, 78 (13)
  • [46] AN OPEN-LABEL PHASE I DOSE-ESCALATION CLINICAL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC PROFILE AND PRELIMINARY EFFICACY OF VG161 IN PATIENTS WITH ADVANCED PRIMARY LIVER CANCER
    Shen, Yinan
    Shi, Guoming
    Liang, Xingmei
    Jin, Xinyan
    Wang, Youlei
    Wei, Guyue
    Chen, Yi
    Huang, Xiaoyong
    Lu, Jiacheng
    Xia, Huiqun
    Xiao, Miao
    Rahimian, Shah
    Zhao, Ronghua
    Li, Yuwei
    Lin, Danni
    Fang, Tian
    Chen, Wei
    Ma, Tao
    Bai, Xueli
    Liang, Tingbo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A725 - A725
  • [47] Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial
    Qiang Zhou
    Zhiqiang Wang
    Heming Wang
    Zhidong Chen
    Xiaoyi Li
    Xiangrong Dai
    Yong Zhang
    Xiaohui Yu
    Renpeng Zhou
    Wei Hu
    American Journal of Cardiovascular Drugs, 2023, 23 : 101 - 112
  • [48] Dose-escalation phase III trial of preoperative chemoradiotherapy in rectal cancer. First results
    Lopez Campos, F.
    Martin Martin, M.
    Isabel, R.
    Belinchon, B.
    Morillo, V.
    Jorda, E.
    Peleteiro, P.
    Fuertes, F. J.
    Matute, R.
    De las Penas Cabrera, M. D.
    Hervas, A.
    Duque, V.
    Caminoa-Lizarralbe, A.
    Die, J.
    Garcia Perez, J. C.
    Pachon, V.
    Ferreiro, R.
    Garcia Latorre, R.
    Canales, E.
    Moreno, I.
    Torabuela, E.
    Pina, J. D.
    Abadia, P.
    Morera, R.
    Sancho, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S295 - S295
  • [49] Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial
    Zhou, Qiang
    Wang, Zhiqiang
    Wang, Heming
    Chen, Zhidong
    Li, Xiaoyi
    Dai, Xiangrong
    Zhang, Yong
    Yu, Xiaohui
    Zhou, Renpeng
    Hu, Wei
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (01) : 101 - 112
  • [50] A phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in metastatic colorectal cancer.
    Hollebecque, Antoine
    Argiles, Guillem
    Andre, Thierry
    Cervantes, Andres
    Leger, Catherine
    Valette, Aude
    Amellal, Nadia
    Fougeray, Ronan
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345